See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2026_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.7690964672249744, 'aggregate_val': 3034747000, 'exp_sum': 1715422000, 'exp_to_value': {'LiabilitiesCurrent': 781567000, 'LiabilitiesNoncurrent': 354384000, 'remainder_Liabilities': 579471000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,990,635,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 123,048,000 |
| 3 | remainder_Assets | 410,153,000 |
| 4 | LiabilitiesCurrent | 781,567,000 |
| 5 | LiabilitiesNoncurrent | 354,384,000 |
| 6 | remainder_Liabilities | 1,898,796,000 |
| 7 | CostOfGoodsAndServicesSold | 15,643,744 |
| 8 | SellingGeneralAndAdministrativeExpense | 421,058,902 |
| 9 | ResearchAndDevelopmentExpense | 948,924,142 |
| 10 | remainder_Expenses | 178,963,854 |
| 11 | remainder_Revenues | 901,307,287 |
| 12 | remainder_NetIncome | 95,724,392 |
| 13 | remainder_ComprehensiveNetIncome | 11,837,882 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,523,836,000 |
| 1 | Liabilities | 3,034,747,000 |
| 2 | Expenses | 1,564,590,642 |
| 3 | Revenues | 901,307,287 |
| 4 | StockholdersEquity | 489,089,000 |
| 5 | NetIncome | -567,558,963 |
| 6 | ComprehensiveNetIncome | -561,640,022 |
| 7 | BaseVar | 4,566,021,602 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.154 |
| 9 | EconomicCapitalRatio | 1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
